%PDF-1.7
%
1 0 obj
<<
/Names 2 0 R
/Type /Catalog
/Outlines 3 0 R
/PageLayout /SinglePage
/PageLabels 4 0 R
/OpenAction [5 0 R /FitH 10000]
/Metadata 6 0 R
/StructTreeRoot 7 0 R
/Lang (en)
/MarkInfo 8 0 R
/PageMode /UseOutlines
/Pages 9 0 R
>>
endobj
10 0 obj
<<
/Creator (Elsevier)
/CrossMarkDomains#5B1#5D (elsevier.com)
/CrossmarkMajorVersionDate (2010-04-23)
/CreationDate--Text (11th January 2023)
/ElsevierWebPDFSpecifications (7.0)
/robots (noindex)
/ModDate (D:20230111155815Z)
/Author (Clifford J. Bailey)
/doi (10.1016/j.peptides.2023.170939)
/Keywords (Glucagon,GLP-1,GIP,Type 2 diabetes,Obesity,Semaglutide,Tirzepatide,Cagrilintide)
/Producer (Acrobat Distiller 8.1.0 \(Windows\))
/CreationDate (D:20221214073610Z)
/Title (An update on peptide-based therapies for type 2 diabetes and obesity)
/Subject (Peptides, 161 \(2023\) 170939. doi:10.1016/j.peptides.2023.170939)
/CrossMarkDomains#5B2#5D (sciencedirect.com)
/CrossmarkDomainExclusive (true)
>>
endobj
2 0 obj
<<
/Dests 11 0 R
>>
endobj
3 0 obj
<<
/First 12 0 R
/Last 12 0 R
/Count 1
>>
endobj
4 0 obj
<<
/Nums [0 13 0 R]
>>
endobj
5 0 obj
<<
/Type /Page
/Contents 14 0 R
/Resources <<
/XObject 15 0 R
/Font 16 0 R
/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]
>>
/MediaBox [0 0 595.276001 793.700989]
/Parent 9 0 R
/StructParents 16
/Annots [17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R
27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
/CropBox [0 0 595.276001 793.700989]
/Tabs /S
>>
endobj
6 0 obj
<<
/Length 5709
/Subtype /XML
/Type /Metadata
>>
stream
application/pdf
10.1016/j.peptides.2023.170939
Elsevier Inc.
Peptides, 161 (2023) 170939. doi:10.1016/j.peptides.2023.170939
Glucagon
GLP-1
GIP
Type 2 diabetes
Obesity
Semaglutide
Tirzepatide
Cagrilintide
An update on peptide-based therapies for type 2 diabetes and obesity
Clifford J. Bailey
Peter R. Flatt
J. Michael Conlon
journal
Peptides
© 2023 The Author(s). Published by Elsevier Inc.
0196-9781
161
1 March 2023
2023-03-01
170939
170939
10.1016/j.peptides.2023.170939
https://doi.org/10.1016/j.peptides.2023.170939
2010-04-23
true
10.1016/j.peptides.2023.170939
elsevier.com
sciencedirect.com
http://creativecommons.org/licenses/by/4.0/
VoR
10.1016/j.peptides.2023.170939
noindex
2010-04-23
true
11th January 2023
sciencedirect.com
elsevier.com
Elsevier
2023-01-11T15:58:15
2022-12-14T07:36:10
2023-01-11T15:58:15
True
11th January 2023
Acrobat Distiller 8.1.0 (Windows)
Glucagon,GLP-1,GIP,Type 2 diabetes,Obesity,Semaglutide,Tirzepatide,Cagrilintide
uuid:1b499bed-4ce8-4c0c-b682-0d58baae1cbe
uuid:b6ed5266-03cb-4855-90c0-636283357f42
endstream
endobj
7 0 obj
<<
/Type /StructTreeRoot
/K 36 0 R
/RoleMap 37 0 R
/ParentTree 38 0 R
/ParentTreeNextKey 123
>>
endobj
8 0 obj
<<
/Marked true
>>
endobj
9 0 obj
<<
/Count 7
/Kids [39 0 R 5 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R]
/Type /Pages
>>
endobj
11 0 obj
<<
/Kids [45 0 R 46 0 R 47 0 R]
>>
endobj
12 0 obj
<<
/Parent 3 0 R
/Dest (mk:title)
/Last 48 0 R
/Title (An update on peptide-based therapies for type 2 diabetes and obesity)
/First 49 0 R
/Count 17
>>
endobj
13 0 obj
<<
/S /D
/St 1
>>
endobj
14 0 obj
<<
/Length 9396
/Filter /FlateDecode
>>
stream
x=ے\qyޯّ)1"EqH\
lTe+E2Mbn9gݡd@hƜ4לhƛx?fszٛ߾_;}/o7.hl9l&(W'DrooT.$~ zsK@) $2d@' jw֝l.?8
ٛ?~ݻ/yz/o>g_*|߰?EakOp^{xdϿN>}o.~zO
)z2/;.oxm[#*#YF 2k~,7,|oEU9jmd[#&K:ȒIK|[5JGwwKљSlwLLF
$
bi[YyWϫ3Zy3C1 9E,wڅT- DBrƓ6cʦMo"Vקܜɘt`*vbS=ǕN0 h